Clinical Trials
- Child Development & Autism, Genetics, Mental Health & Behavioral Research
Pivotal Response Treatment for Children With Autism Spectrum Disorders (PRT)
- Ages4 years - 35 years
- GenderBoth
- Child Development & Autism, Children's Health, Mental Health & Behavioral Research
Comparing F4C to Batterer Intervention
- Ages18 years and older
- GenderMale only
- Pancreatic Cancer
Phase II Randomized, Prospective Trial of Lutetium Lu 177 Dotatate PRRT Versus Capecitabine and Temozolomide in Well-Differentiated Pancreatic Neuroendocrine Tumors
- Child Development & Autism
TMS to Treat Core Social Deficits in Autism Spectrum Disorder
- Ages18 years - 30 years
- GenderBoth
- Child Development & Autism, Children's Health, Mental Health & Behavioral Research
Anger Control Training for Youth With Tourette Syndrome
- Ages11 years - 16 years
- GenderBoth
- Child Development & Autism, Children's Health, Mental Health & Behavioral Research
CBT for Anxiety in Children With Autism
- Ages8 years - 14 years
- GenderBoth
- Prostate Cancer
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
- Brain, Spinal Cord & Nervous System
Imaging pancreatic beta-cells with PET neuroimaging agent 11C-PHNO
- Ages18 years - 65 years
- GenderBoth
- Thyroid and Other Endocrine Cancers, Pancreatic Cancer
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
- Prostate Cancer, Bladder Cancer
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung